Open | - |
Close | - |
Volume / Avg. | 0 / 843.894K |
Day Range | - - - |
52 Wk Range | 19.795 - 35.500 |
Market Cap | $1.646B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 13.77% |
Days to Cover | 10.56 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Agios Pharmaceuticals (NASDAQ: AGIO) through any online brokerage.
Other companies in Agios Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Agios Pharmaceuticals (NASDAQ: AGIO) was reported by JP Morgan on Friday, February 23, 2024. The analyst firm set a price target for 30.00 expecting AGIO to rise to within 12 months (a possible 2.42% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $29.29 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Agios Pharmaceuticals.
Agios Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Agios Pharmaceuticals.
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.